National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland Department of Tuberculosis Epidemiology and Surveillance.
National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland, the Institute Director.
Przegl Epidemiol. 2021;75(2):192-209. doi: 10.32394/pe.75.18.
To evaluate the main features of epidemiology of tuberculosis (TB) in 2019 in Poland and to compare with the situation in the European Union and European Economic Area (EU/EEA) countries.
Analysis of case-based data on TB patients from National TB Register, data on anti-TB drug susceptibility in cases notified in 2019, data from Central Statistical Office on deaths from tuberculosis in 2018, data from National Institute of Public Health - National Institute of Hygiene on HIV-positive subjects for whom TB was an AIDS-defining disease, data from the report "European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2021 - 2019 data".
In 2019, 5321 TB cases were reported in Poland. The incidence rate was 13.9 cases per 100,000 with large variability between voivodeships from 8.0 to 20.0 per 100,000. The number of all pulmonary tuberculosis cases was 5075 i.e. 13.2 per 100,000. Pulmonary cases represented 95.4% of all TB cases. In 2019, 246 extrapulmonary TB cases were notified (4.6% of all TB cases). Pulmonary tuberculosis was bacteriologically confirmed in 3926 cases (77.4% of all pulmonary TB cases, the incidence rate 10.2 per 100,000). The number of smear-positive pulmonary TB cases was 2565 i.e. 6.7 per 100,000 ( 48.2% of all pulmonary TB cases). In 2019, there were 41 cases (18 of foreign origin) with multidrug resistant TB (MDR-TB) representing 1.1% of cases with known drug sensitivity. The incidence rates of tuberculosis were growing along with the age group from 1.4 per 100,000 among children (0-14 years) to 23.9 per 100,000 among subjects in the age group 45-64 years, the incidence rate in the age group ≥65 years was 19.8 per 100,000. There were 81 cases in children up to 14 years of age (1.5% of the total) and 48 cases in adolescents between 15 and 19 years of age - rates 1.4 and 2.6 per 100,000 respectively. In 2019, there were 3897 cases of tuberculosis in men and 1424 in women. The TB incidence in men - 21.0 per 100,000 was 2.9 times higher than among women - 7.2. The biggest difference in the TB incidence between the two sex groups occurred in persons aged 50-54 years - 40.2 vs. 8.1 and in age group 55 to 59 years - 45.1 vs. 9.0. In 2019, there were 121 patients of foreign origin among all cases of tuberculosis in Poland (2.3%). In 2018, TB was the cause of death for 519 people (mortality rate - 1.4 per 100,000).
TB incidence in Poland in 2019 was lower than in the previous year. Differences in incidence between voivodships persist. The percentage of TB cases with bacteriological confirmation exceeded 75%, more than in EU/EEA countries (67.1%). In Poland, MDR-TB is less common than the average in the EU/EEA countries. In Poland, the highest incidence rates are found in older age groups. The percentage of children up to 14 years of age among all TB patients was 1.5%, lower than the average in EU/EEA countries (3.9%). The incidence of tuberculosis in men is nearly three times as high as in women. The impact of migration on the characteristics of tuberculosis in Poland is not substantial. The percentage of foreign-born persons among TB patients is low.
评估 2019 年波兰结核病(TB)流行病学的主要特征,并与欧盟和欧洲经济区(EU/EEA)国家的情况进行比较。
分析国家结核病登记处的结核病患者基于病例的数据、2019 年报告的抗结核药物敏感性病例数据、2018 年中央统计局关于结核病死亡数据、国家公共卫生研究所-国家卫生研究所关于 HIV 阳性者结核病为艾滋病定义性疾病的数据、欧洲疾病预防控制中心/世界卫生组织欧洲区域办事处的报告“欧洲结核病监测和监测 2021-2019 年数据”。
2019 年,波兰报告了 5321 例结核病病例。发病率为每 10 万人 13.9 例,各省份之间差异很大,从每 10 万人 8.0 例到 20.0 例不等。所有肺结核病例数为 5075 例,即每 10 万人 13.2 例。肺结核病例占所有结核病病例的 95.4%。2019 年,报告了 246 例肺外结核病病例(所有结核病病例的 4.6%)。3926 例肺结核病例经细菌学证实(所有肺结核病例的 77.4%,发病率为每 10 万人 10.2 例)。56 例涂阳肺结核病例,即每 10 万人 6.7 例(所有肺结核病例的 48.2%)。2019 年,有 41 例(18 例为外国来源)耐多药结核病(MDR-TB),占已知药物敏感性病例的 1.1%。结核病发病率随着年龄组的增长而增加,从儿童(0-14 岁)的每 10 万人 1.4 例到 45-64 岁年龄组的每 10 万人 23.9 例,65 岁及以上年龄组的发病率为每 10 万人 19.8 例。在儿童(0-14 岁)中,有 81 例(占总数的 1.5%),在 15-19 岁的青少年中,有 48 例,分别为每 10 万人 1.4 和 2.6 例。2019 年,男性结核病病例 3897 例,女性 1424 例。男性结核病发病率为每 10 万人 21.0,是女性每 10 万人 7.2 的 2.9 倍。两个性别组之间结核病发病率的最大差异发生在 50-54 岁年龄组,分别为 40.2 比 8.1 和 55-59 岁年龄组,分别为 45.1 比 9.0。2019 年,波兰所有结核病病例中有 121 例为外国来源(2.3%)。2018 年,结核病是 519 人死亡的原因(死亡率为每 10 万人 1.4)。
2019 年波兰的结核病发病率低于前一年。各省份之间的发病率差异仍然存在。经细菌学证实的结核病病例比例超过 75%,高于欧盟/EEA 国家(67.1%)。波兰的耐多药结核病病例比欧盟/EEA 国家平均水平少。在波兰,发病率最高的是年龄较大的年龄组。14 岁以下儿童占所有结核病患者的 1.5%,低于欧盟/EEA 国家的平均水平(3.9%)。男性结核病发病率几乎是女性的三倍。移民对波兰结核病特征的影响不大。在结核病患者中,外国出生人口的比例较低。